Skip to main content
. 2013 Jul 13;14:96. doi: 10.1186/1471-2296-14-96

Table 3.

Comparison between general characteristics of control group and intervention group

  Control group Intervention group P
Sex
 
%(n)
 
 
0.75a
 
Women
 
68.7 (121)
59.2(103)
 
 
Men
 
31.3(55)
40.8(71)
 
 
Overall
 
100(176)
100.0(174)
 
Mean ± SD
 
 
 
Age (years)
83.3 ± 6.9
80.8 ± 7.3
0.001b
Weight (kg)
65.5 ± 12.1
66.8 ± 12.0
0.335b
Height (m)
1.6 ± 0.1
1.6 ± 0.1
0.069b
BMI (Kg/m2)
26.1 ± 4.0
26.3 ± 3.8
0.721b
SBP (mm Hg)
130.7 ± 17.3
134.7 ± 18.7
0.060b
DBP (mm Hg)
71.5 ± 11.3
75.0 ± 12.3
0.012b
Creatinine (mg/dl)
1.1 ± 0.4
1.2 ± 0.8
0.052b
Body surface (m2)
1.7 ± 0.2
1.7 ± 0.2
0.162b
GFR (ml/min/1.73 m2)
61.7 ± 16.5
60.7 ± 17.0
0.572b
CrCl (ml/min)
45.0 ± 12.1
45. + ±13.0
0.525b
CrCl-BS (ml/min/1.73 m2)
46.3 ± 11.6
47.1 ± 12.6
0.550b
Total number of drugs per patient
7.3 ± 2.9
6.3 ± 3.2
0.003b
Drugs with restriction in RI per patient
4.0 ± 2.0
3.5 ± 2.1
0.069b
Number of DRP per patient
0.7 ± 1.0
0.5 ± 1.0
0.164b
Prevalence of DI (%)
17.5 ± 28.2
15.5 ± 29.1
0.514b
Comorbidity %(n)
 
 
 
 Hypertension
72.2(127)
69.5(121)
0.639a
 T2DM
23.9(42)
11.5(20)
0.003a
 Dyslipidemia
39.8(70)
37.4(65)
0.662a
 Hyper/Hypo Thyroidism
5.7(10)
6.3(11)
0.826a
 CVD
30.7(54)
23.6(41)
0.150a
 CKD 10.2(18) 8.0(14) 0.579a

Abbreviations: BMI Body Mass Index, SBP Systolic Blood Pressure, DBP, Diastolic Blood Pressure, T2DM Type 2 Diabetes Mellitus, CVD Cardiovascular Disease, CKD Chronic Kidney Disease, GFR Rate of Glomerular filtration, CrCl Creatinine Clearance, CrCl-BS Creatinine Clearace adjusted to body surface, RI renal impairment, DRP Drug-related problem, DI Dosing inadequacy, Drugs with restrictions (dose adjustment needed in case of renal impairment (RI)) per patient [20-22], SD Standard deviation.

aχ2Test.

b T Student test for independent groups.